2. On the contrary, it underwrites the credibility for leadership on global issues, by seeking to strike two points:
Two excellent questions at the end of a very sensible thread summarising the post-Brexit UK FP debate. My own take at attempting to offer an answer - ahead of the IR is as follow:
Both the @ChathamHouse and @Policy_Exchange reports are excellent and leave a healthy tension to the UK foreign policy debate. I\u2019m left with two questions that won\u2019t go away. Is the first underestimating how the world has changed. Is the second overestimating Britain\u2019s capacity?
— Ben Judah (@b_judah) January 11, 2021
2. On the contrary, it underwrites the credibility for leadership on global issues, by seeking to strike two points:
B. Propelling the UK towards a more diversified set of economic, political, and security ties;
4. It is as a result a notion that stands on the ability to renew diplomacy;
6. It equally puts a premium on exploring new bilateral and multilateral formats. On former, Japan, Australia. On latter, Quad;
8. All of this based on a prosperity project drawing upon Asia’s emerging energy trade formats.
9. Because of the above, capabilities is an issue only if the UK’s tilt is seen outside of its crucially networked nature. The UK will enable and convene;
More from Brexit
Whether it be Gavin Williamson
or Jeremy Hunt
Why they need this amidst the shitshow of brexit and the disaster of covid?
Is a fascinating question
Is British science the best in the world? My question to the boss of our gold medal winning regulator, Dr June Raine pic.twitter.com/cR9977XeUt
— Jeremy Hunt (@Jeremy_Hunt) December 9, 2020
A reminder
We could only approve this vaccine so quickly because we have left the EU. Last month we changed the regulations so a vaccine did not need EU approval which is slower. https://t.co/y2Az7okPdx
— Jacob Rees-Mogg (@Jacob_Rees_Mogg) December 2, 2020
You May Also Like
Alain Merieux, who owns bioMerieux, was instrumental in the creation of the Wuhan Institute of Virology P4 Lab.
The same people who helped create the virus, also helped to create the vaccines...
Moderna partnered with French Pasteur Institute in 2015 to develop mRNA vaccine technology.
Pasteur Institute partnered with the Wuhan P4 Laboratory in 2017 along with the Merieux Foundation to study emerging viruses...
https://t.co/yFsHwrNYaK
https://t.co/9M5lydBKhM
Nobel prize winning scientist Luc Montagnier asserts that Sars-Cov-2 is man-made and originated from the Wuhan Institute of Virology.
Montagnier did extensive work with the Pasteur Institute in France which was partnered with the Wuhan P4.
Merieux Foundation & the Chinese government have worked together since 1965, and partnered to study emerging pathogens in Africa in 2015.
Their research included "PATHOGENS CARRIED BY BATS" that provoke respiratory diseases.
🚨🚨🚨
https://t.co/gVwpT0ssqI
@NBA @StephenKissler @yhgrad 1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice
1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 30, 2021
"we generated a mouse model expressing hACE2 by using CRISPR/Cas9 knockin technology. In comparison with wild-type C57BL/6 mice, both young & aged hACE2 mice sustained high viral loads... pic.twitter.com/j94XtSkscj
@NBA @StephenKissler @yhgrad 2. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2
1. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2!
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 2, 2021
2 papers:
Human\u2013viral molecular mimicryhttps://t.co/irfH0Zgrve
Molecular Mimicryhttps://t.co/yLQoUtfS6s https://t.co/lsCv2iMEQz
@NBA @StephenKissler @yhgrad B.1.1.7 has an unusually large number of genetic changes, ... found to date in mouse-adapted SARS-CoV2 and is also seen in ferret infections.
https://t.co/9Z4oJmkcKj
@NBA @StephenKissler @yhgrad We adapted a clinical isolate of SARS-CoV-2 by serial passaging in the ... Thus, this mouse-adapted strain and associated challenge model should be ... (B) SARS-CoV-2 genomic RNA loads in mouse lung homogenates at P0 to P6.
https://t.co/I90OOCJg7o